Last 12 months
Inside the activity.
1 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 22, 2024 Filed Aug 27, 2024 00:16 UTC |
McCarthy Daniel JosephPRESIDENT
|
SaleClass A Common Stock | 7,000 | $33.00 | $231,000.00 |
DisclosureSEC source: 0001628908-24-000100 · wk-form4_1724717792.xml · nonDerivative · entry 3 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 198,809 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:16 UTC |
McCarthy Daniel JosephPRESIDENT
|
SaleClass A Common Stock | 16,693 | $30.00 | $500,790.00 |
DisclosureSEC source: 0001628908-24-000100 · wk-form4_1724717792.xml · nonDerivative · entry 2 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,809 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:16 UTC |
McCarthy Daniel JosephPRESIDENT
|
Exercise / conversionClass A Common Stock | 4,550 | $24.75 | $112,612.50 |
DisclosureSEC source: 0001628908-24-000100 · wk-form4_1724717792.xml · nonDerivative · entry 1 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:11 UTC |
Johnson John PaulChief Financial Officer
|
SaleClass A Common Stock | 44,693 | $30.00 | $1,340,790.00 |
DisclosureSEC source: 0001628908-24-000094 · wk-form4_1724717458.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,207 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:13 UTC |
Blackley SethDirector · Chief Executive Officer
|
Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 52,742 | $0.00 Strike: $10.27 | $0.00 |
DisclosureSEC source: 0001628908-24-000096 · wk-form4_1724717593.xml · derivative · entry 7 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 52,742 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024. F7 · derivative.exercise_date: The Class A Common Stock Options exercised vested on March 1, 2020. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:13 UTC |
Blackley SethDirector · Chief Executive Officer
|
Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 35,162 | $0.00 Strike: $10.27 | $0.00 |
DisclosureSEC source: 0001628908-24-000096 · wk-form4_1724717593.xml · derivative · entry 6 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 35,162 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024. F6 · derivative.exercise_date: The Class A Common Stock Options exercised vested on March 1, 2019 and March 1, 2020. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:13 UTC |
Blackley SethDirector · Chief Executive Officer
|
Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $6.87 | $0.00 |
DisclosureSEC source: 0001628908-24-000096 · wk-form4_1724717593.xml · derivative · entry 5 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 100,000 shares Expires 2025-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024. F5 · derivative.exercise_date: The Class A Common Stock Options exercised vested on February 1, 2019. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:13 UTC |
Blackley SethDirector · Chief Executive Officer
|
SaleClass A Common Stock | 187,904 | $30.00 | $5,637,120.00 |
DisclosureSEC source: 0001628908-24-000096 · wk-form4_1724717593.xml · nonDerivative · entry 4 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 411,924 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.02, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:13 UTC |
Blackley SethDirector · Chief Executive Officer
|
Exercise / conversionClass A Common Stock | 52,742 | $10.27 | $541,660.34 |
DisclosureSEC source: 0001628908-24-000096 · wk-form4_1724717593.xml · nonDerivative · entry 3 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 599,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:13 UTC |
Blackley SethDirector · Chief Executive Officer
|
Exercise / conversionClass A Common Stock | 35,162 | $10.27 | $361,113.74 |
DisclosureSEC source: 0001628908-24-000096 · wk-form4_1724717593.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 547,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:13 UTC |
Blackley SethDirector · Chief Executive Officer
|
Exercise / conversionClass A Common Stock | 100,000 | $6.87 | $687,000.00 |
DisclosureSEC source: 0001628908-24-000096 · wk-form4_1724717593.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 511,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. F3 · balance_after: Since the date of the reporting person's last ownership report, Mr. Blackley transferred 348,458 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order. Mr. Blackley no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:08 UTC |
Rafferty Emily AnnChief Operating Officer
|
SaleClass A Common Stock | 8,861 | $30.00 | $265,830.00 |
DisclosureSEC source: 0001628908-24-000092 · wk-form4_1724717306.xml · nonDerivative · entry 1 Rafferty Emily Ann · CIK 0001983577 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,408 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:10 UTC |
Shams AammaadChief Accounting Officer
|
Tax withholdingClass A Common Stock | 2,567 | $22.44 | $57,603.48 |
DisclosureSEC source: 0001628908-24-000082 · wk-form4_1722888634.xml · nonDerivative · entry 1 Shams Aammaad · CIK 0001815354 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,379 F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:33 UTC |
Glass Russell MonroeDirector
|
GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000072 · wk-form4_1718062406.xml · nonDerivative · entry 1 Glass Russell Monroe · CIK 0002012340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,872 F1 · security: Represents restricted stock units granted to Mr. Glass pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:34 UTC |
KECK KIMDirector
|
GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000073 · wk-form4_1718062440.xml · nonDerivative · entry 1 KECK KIM · CIK 0001818332 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,982 F1 · security: Represents restricted stock units granted to Ms. Keck pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:32 UTC |
Jelinek Richard MDirector
|
GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000070 · wk-form4_1718062338.xml · nonDerivative · entry 1 Jelinek Richard M · CIK 0001707429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,458 F1 · security: Represents restricted stock units granted to Mr. Jelinek pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 19:35 UTC |
Holder DianeDirector
|
GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000075 · wk-form4_1718062506.xml · nonDerivative · entry 1 Holder Diane · CIK 0001642976 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,849 F1 · security: Represents restricted stock units granted to Ms. Holder pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:36 UTC |
GRUA PETER JDirector
|
GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000077 · wk-form4_1718062582.xml · nonDerivative · entry 1 GRUA PETER J · CIK 0001242813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,758 F1 · security: Represents restricted stock units granted to Mr. Grua pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:31 UTC |
Barbarosh Craig A.Director
|
GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000069 · wk-form4_1718062292.xml · nonDerivative · entry 1 Barbarosh Craig A. · CIK 0001472457 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,956 F1 · security: Represents restricted stock units granted to Mr. Barbarosh pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 19:34 UTC |
DUFFY MARY BRIDGETDirector
|
GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000074 · wk-form4_1718062477.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,001 F1 · security: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. F3 · balance_after: Since the date of the reporting person's last ownership report, Dr. Duffy transferred 9,643 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order. Dr. Duffy no longer reports as beneficially owned any securities owned by her ex-spouse. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:35 UTC |
Scott CherylDirector
|
GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000076 · wk-form4_1718062537.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,497 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:32 UTC |
Ajayi ToyinDirector
|
GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000071 · wk-form4_1718062368.xml · nonDerivative · entry 1 Ajayi Toyin · CIK 0001988404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,095 F1 · security: Represents restricted stock units granted to Dr. Ajayi pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| March 02, 2024 Filed Mar 6, 2024 00:12 UTC |
Weinberg JonathanGeneral Counsel
|
Tax withholdingClass A Common Stock | 4,830 | $34.41 | $166,200.30 |
DisclosureSEC source: 0001628908-24-000036 · wk-form4_1709683930.xml · nonDerivative · entry 3 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,027 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 02, 2024 Filed Mar 6, 2024 00:09 UTC |
Johnson John PaulChief Financial Officer
|
Tax withholdingClass A Common Stock | 9,020 | $34.41 | $310,378.20 |
DisclosureSEC source: 0001628908-24-000034 · wk-form4_1709683768.xml · nonDerivative · entry 3 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,900 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 02, 2024 Filed Mar 6, 2024 00:03 UTC |
McCarthy Daniel JosephPRESIDENT
|
Tax withholdingClass A Common Stock | 5,638 | $34.41 | $194,003.58 |
DisclosureSEC source: 0001628908-24-000030 · wk-form4_1709683408.xml · nonDerivative · entry 3 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,952 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:24 UTC |
Glass Russell MonroeDirector
|
GrantClass A Common Stock | 1,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000042 · wk-form4_1709684662.xml · nonDerivative · entry 1 Glass Russell Monroe · CIK 0002012340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,163 F1 · security: Represents restricted stock units granted to Mr. Glass pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of March 1, 2025 and the date of the Company's 2024 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:18 UTC |
Shams AammaadChief Accounting Officer
|
Tax withholdingClass A Common Stock | 2,569 | $34.41 | $88,399.29 |
DisclosureSEC source: 0001628908-24-000040 · wk-form4_1709684281.xml · nonDerivative · entry 2 Shams Aammaad · CIK 0001815354 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,946 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:18 UTC |
Shams AammaadChief Accounting Officer
|
GrantClass A Common Stock | 7,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000040 · wk-form4_1709684281.xml · nonDerivative · entry 1 Shams Aammaad · CIK 0001815354 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,515 F1 · security: Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:12 UTC |
Weinberg JonathanGeneral Counsel
|
Tax withholdingClass A Common Stock | 7,460 | $34.41 | $256,698.60 |
DisclosureSEC source: 0001628908-24-000036 · wk-form4_1709683930.xml · nonDerivative · entry 2 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,857 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:12 UTC |
Weinberg JonathanGeneral Counsel
|
GrantClass A Common Stock | 21,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000036 · wk-form4_1709683930.xml · nonDerivative · entry 1 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,317 F1 · security: Represents restricted stock units granted to Mr. Weinberg pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:15 UTC |
Rafferty Emily AnnChief Operating Officer
|
Tax withholdingClass A Common Stock | 7,049 | $34.41 | $242,556.09 |
DisclosureSEC source: 0001628908-24-000038 · wk-form4_1709684130.xml · nonDerivative · entry 2 Rafferty Emily Ann · CIK 0001983577 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,269 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:15 UTC |
Rafferty Emily AnnChief Operating Officer
|
GrantClass A Common Stock | 10,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000038 · wk-form4_1709684130.xml · nonDerivative · entry 1 Rafferty Emily Ann · CIK 0001983577 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,318 F1 · security: Represents restricted stock units granted to Ms. Rafferty pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:09 UTC |
Johnson John PaulChief Financial Officer
|
Tax withholdingClass A Common Stock | 11,213 | $34.41 | $385,839.33 |
DisclosureSEC source: 0001628908-24-000034 · wk-form4_1709683768.xml · nonDerivative · entry 2 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,920 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:09 UTC |
Johnson John PaulChief Financial Officer
|
GrantClass A Common Stock | 12,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000034 · wk-form4_1709683768.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,133 F1 · security: Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:06 UTC |
Blackley SethDirector · Chief Executive Officer
|
Tax withholdingClass A Common Stock | 24,005 | $34.41 | $826,012.05 |
DisclosureSEC source: 0001628908-24-000032 · wk-form4_1709683577.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 760,382 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:06 UTC |
Blackley SethDirector · Chief Executive Officer
|
GrantClass A Common Stock | 29,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000032 · wk-form4_1709683577.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 784,387 F1 · security: Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:03 UTC |
McCarthy Daniel JosephPRESIDENT
|
Tax withholdingClass A Common Stock | 13,210 | $34.41 | $454,556.10 |
DisclosureSEC source: 0001628908-24-000030 · wk-form4_1709683408.xml · nonDerivative · entry 2 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,590 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:03 UTC |
McCarthy Daniel JosephPRESIDENT
|
GrantClass A Common Stock | 19,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000030 · wk-form4_1709683408.xml · nonDerivative · entry 1 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,800 F1 · security: Represents restricted stock units granted to Mr. McCarthy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:38 UTC |
Weinberg JonathanGeneral Counsel
|
Tax withholdingClass A Common Stock | 4,024 | $33.03 | $132,912.72 |
DisclosureSEC source: 0001628908-24-000019 · wk-form4_1708983497.xml · nonDerivative · entry 2 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,495 F3 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:38 UTC |
Weinberg JonathanGeneral Counsel
|
GrantClass A Common Stock | 11,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000019 · wk-form4_1708983497.xml · nonDerivative · entry 1 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,519 F1 · shares: Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:48 UTC |
Blackley SethDirector · Chief Executive Officer
|
Tax withholdingClass A Common Stock | 88,563 | $33.03 | $2,925,235.89 |
DisclosureSEC source: 0001628908-24-000025 · wk-form4_1708984079.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 755,291 F3 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:48 UTC |
Blackley SethDirector · Chief Executive Officer
|
GrantClass A Common Stock | 206,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000025 · wk-form4_1708984079.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 843,854 F1 · shares: Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:46 UTC |
McCarthy Daniel JosephPRESIDENT
|
Tax withholdingClass A Common Stock | 8,431 | $33.03 | $278,475.93 |
DisclosureSEC source: 0001628908-24-000023 · wk-form4_1708983968.xml · nonDerivative · entry 2 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,402 F3 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:46 UTC |
McCarthy Daniel JosephPRESIDENT
|
GrantClass A Common Stock | 27,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000023 · wk-form4_1708983968.xml · nonDerivative · entry 1 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,833 F1 · shares: Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:43 UTC |
Johnson John PaulChief Financial Officer
|
Tax withholdingClass A Common Stock | 20,006 | $33.03 | $660,798.18 |
DisclosureSEC source: 0001628908-24-000021 · wk-form4_1708983759.xml · nonDerivative · entry 2 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,010 F3 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:43 UTC |
Johnson John PaulChief Financial Officer
|
GrantClass A Common Stock | 44,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000021 · wk-form4_1708983759.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,016 F1 · shares: Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 21:49 UTC |
Blackley SethDirector · Chief Executive Officer
|
SaleClass A Common Stock | 20,900 | $27.25 | $569,525.00 |
DisclosureSEC source: 0001628908-23-000185 · wk-form4_1701899379.xml · nonDerivative · entry 4 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 637,645 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2023. F5 · shares: This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.07 to $27.42, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 21:49 UTC |
Blackley SethDirector · Chief Executive Officer
|
SaleClass A Common Stock | 92,616 | $26.61 | $2,464,511.76 |
DisclosureSEC source: 0001628908-23-000185 · wk-form4_1701899379.xml · nonDerivative · entry 3 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 658,545 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2023. F5 · shares: This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.05 to $27.04, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 21:49 UTC |
Blackley SethDirector · Chief Executive Officer
|
SaleClass A Common Stock | 27,484 | $25.74 | $707,438.16 |
DisclosureSEC source: 0001628908-23-000185 · wk-form4_1701899379.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 751,161 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2023. F5 · shares: This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.05 to $26.04, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:49 UTC |
Blackley SethDirector · Chief Executive Officer
|
Exercise / conversionLeveraged Restricted Stock Unit · Derivative | 280,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628908-23-000185 · wk-form4_1701899379.xml · derivative · entry 5 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 280,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These LSUs vested on December 4, 2023. F10 · derivative.expiration_date: These LSUs do not expire. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.